epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Anzupgo
    delgocitinib topical
  • remove apomorphine
    generic
  • remove Coricidin HBP Maximum Strength Cold, Flu & Chest Congestion
    acetaminophen/ guaifenesin
  • remove Firvanq
    vancomycin
  • remove Gazyva
    obinutuzumab

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face apomorphine (generic) + Gazyva (obinutuzumab)

Monitor/Modify Tx


apomorphine + obinutuzumab

monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

Smiley face Smiley face Firvanq (vancomycin) + Gazyva (obinutuzumab)

Monitor/Modify Tx


vancomycin + obinutuzumab

VANCOMYCIN IV: monitor CBC, especially w/ long-term vancomycin; VANCOMYCIN PO use OK: combo may incr. risk of myelosuppression (additive effects)

Caution Advised

Smiley face Smiley face Anzupgo (delgocitinib topical) + Gazyva (obinutuzumab)

Caution Advised


delgocitinib topical + obinutuzumab

caution advised: combo may incr. risk of serious infection (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information